MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
This randomized, double-blind phase 3 trial tested MDMA-assisted therapy versus placebo with the same therapy in 90 adults with severe PTSD. Participants had three drug sessions plus preparatory and integration therapy, and were assessed 18 weeks after starting. The MDMA group had larger drops in PTSD symptoms and in functional…